An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Academy Recognizes First Distinguished Fellows of the American Academy of Audiology (DFAAA)
The American Academy of Audiology is proud to announce the inaugural cohort of Distinguished Fellows of the American Academy of Audiology (DFAAA), a prestigious honor…
The Government Is Shutdown, Now What?
Congress has failed to avert a government shutdown. The Department of Health and Human Services (HHS) is expected to face significant workforce reductions across its…
Meet the Academy Board of Directors
The American Academy of Audiology is proud to announce its Board of Directors, a group of dedicated leaders guiding the profession forward and ensuring the…